TD Asset Management’s Krystal Biotech KRYS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.76M | Sell |
20,080
-20,188
| -50% | -$2.78M | ﹤0.01% | 870 |
|
|
2025
Q1 | $7.26M | Sell |
40,268
-3,212
| -7% | -$579K | 0.01% | 715 |
|
|
2024
Q4 | $6.81M | Buy |
43,480
+10,000
| +30% | +$1.57M | 0.01% | 727 |
|
|
2024
Q3 | $5.93M | Sell |
33,480
-24,600
| -42% | -$4.36M | 0.01% | 761 |
|
|
2024
Q2 | $10.7M | Sell |
58,080
-11,082
| -16% | -$2.04M | 0.01% | 609 |
|
|
2024
Q1 | $12.3M | Buy |
69,162
+28,200
| +69% | +$5.02M | 0.01% | 588 |
|
|
2023
Q4 | $5.08M | Buy |
40,962
+18,542
| +83% | +$2.3M | 0.01% | 765 |
|
|
2023
Q3 | $2.6M | Buy |
22,420
+6,610
| +42% | +$767K | ﹤0.01% | 885 |
|
|
2023
Q2 | $1.86M | Buy |
+15,810
| New | +$1.86M | ﹤0.01% | 982 |
|
|
2020
Q4 | – | Sell |
-15,922
| Closed | -$685K | – | 1456 |
|
|
2020
Q3 | $685K | Sell |
15,922
-8,833
| -36% | -$380K | ﹤0.01% | 1170 |
|
|
2020
Q2 | $1.03M | Buy |
24,755
+4,000
| +19% | +$166K | ﹤0.01% | 1054 |
|
|
2020
Q1 | $897K | Sell |
20,755
-5,300
| -20% | -$229K | ﹤0.01% | 1029 |
|
|
2019
Q4 | $1.44M | Buy |
26,055
+600
| +2% | +$33.2K | ﹤0.01% | 1009 |
|
|
2019
Q3 | $884K | Buy |
25,455
+5,400
| +27% | +$188K | ﹤0.01% | 1077 |
|
|
2019
Q2 | $808K | Buy |
20,055
+11,902
| +146% | +$480K | ﹤0.01% | 1092 |
|
|
2019
Q1 | $268K | Buy |
+8,153
| New | +$268K | ﹤0.01% | 1274 |
|